HAPLN1


Summary:

NameOMIM IDEnsembl IDHGNC IDPHARMGKB IDMap Location
hyaluronan and proteoglycan link protein 1MIM:115435Ensembl:ENSG00000145681HGNC:HGNC:2380PA269015q14.3

Gene Categories:

DRUGGABLE GENOME

GO terms in HAPLN1


Term TypeEvidence TypeGO Term IDGO Des.
MFHDAGO:0030021extracellular matrix structural constituent conferring compression resistance
BPIBAGO:0001501skeletal system development
BPIEAGO:0007155cell adhesion
BPIBAGO:0007417central nervous system development
BPTASGO:0030198extracellular matrix organization
CCTASGO:0005576extracellular region
CCTASGO:0031012extracellular matrix
CCHDAGO:0062023collagen-containing extracellular matrix
CCHDAGO:0062023collagen-containing extracellular matrix

Gene expression in normal tissue: HAPLN1

Gene-model tissue-cancer distribution: Bubble Plot

Gene-drug pathway distribution

Pathways in HAPLN1


DatabasePathway IDPathway Des.
reactomeR-HSA-1474244Extracellular matrix organization
reactomeR-HSA-3000178ECM proteoglycans

Gene-Drug: Aster Plot


Drug IDDrug NameModel Num.
iGMDRD150RITA2
iGMDRD560MK-22063
iGMDRD424Tamatinib3
iGMDRD462OSI-906 (Linsitinib)1
iGMDRD126Tipifarnib2
iGMDRD151CHM-13
iGMDRD330BRD41321
iGMDRD599Salermide6
iGMDRD579PF7502
iGMDRD1008SR-II-138A2
iGMDRD420Leucascandrolide A3
iGMDRD123Isoevodiamine6
iGMDRD154NSC237664
iGMDRD446LY 21832404
iGMDRD85Ursolic acid3
iGMDRD639YK 4-2793
iGMDRD193Fqi15
iGMDRD103SN-382
iGMDRD138PX 122
iGMDRD260FQI-24
iGMDRD5Tyrphostin AG 14783
iGMDRD300Tozasertib2
iGMDRD64Parbendazole5
iGMDRD356PNU-746542
iGMDRD100Zebularine2
iGMDRD399Selumetinib2
iGMDRD506Fedratinib3
iGMDRD269Purmorphamine2

Gene in drug-gene network: Network Plot

Gene-drug targets distribution

Gene Structure: PDB

Models in HAPLN1

​​​​